SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

09 Oct 2023 16:45:19 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City

27 Sep 2023 16:15:50 By Nasdaq GlobeNewswire

Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

09 Sep 2023 20:00:30 By Nasdaq GlobeNewswire

Supernus to Participate in the Wells Fargo Healthcare Conference

31 Aug 2023 17:30:19 By Nasdaq GlobeNewswire

Bethany L. Sensenig Joins Supernus’ Board of Directors

21 Aug 2023 09:00:54 By Nasdaq GlobeNewswire

Supernus Announces Second Quarter 2023 Financial Results

08 Aug 2023 16:17:24 By Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies Healthcare Conference

31 May 2023 16:15:48 By Nasdaq GlobeNewswire

Supernus Announces First Quarter 2023 Financial Results

09 May 2023 16:05:45 By Nasdaq GlobeNewswire

Supernus to Present at the Bank of America 2023 Health Care Conference

02 May 2023 16:05:34 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023

25 Apr 2023 16:15:00 By Nasdaq GlobeNewswire

Supernus Announces Repayment of Convertible Notes

03 Apr 2023 16:05:02 By Nasdaq GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences

08 Mar 2023 16:05:07 By Nasdaq GlobeNewswire

Supernus to Present at the Cowen 43rd Annual Health Care Conference

01 Mar 2023 16:55:45 By Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

28 Feb 2023 16:05:33 By Nasdaq GlobeNewswire

Supernus Enters Into $150 Million Credit Facility

14 Feb 2023 16:30:00 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023

09 Feb 2023 18:15:05 By Nasdaq GlobeNewswire

Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference

22 Nov 2022 17:00:00 By Nasdaq GlobeNewswire

Supernus to Present at Two November Healthcare Conferences

08 Nov 2022 17:30:00 By Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2022 Financial Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022

25 Oct 2022 16:30:00 By Nasdaq GlobeNewswire